Table 1.
Patient demographics.
| Characteristics | Patients, n = 914 (%) |
|---|---|
| Age, median | 63 (33–88) |
| Sex | |
| Male | 538 (58.9%) |
| Female | 376 (41.1%) |
| Operation Whipple/PPPD/PrPD Distal pancreatectomy Total pancreatectomy |
606 (66.3%) 257 (28.1%) 51 (5.6%) |
| CA 19-9 Normal Elevated (>37 U/mL) |
306 (33.5%) 608 (66.5%) |
| T stage T1 and T2 T3 and T4 |
735 (80.4%) 179 (19.6%) |
| LN metastasis Absent Present |
351 (38.4%) 563 (61.6%) |
| TNM stage (AJCC 8th) I II III |
297 (32.5%) 439 (48%) 178 (19.5%) |
| Resection margin status Negative Positive |
656 (71.8%) 258 (28.2%) |
| mGPS 0 1 2 |
739 (80.9%) 60 (6.6%) 115 (12.6%) |
| NLR <3 ≥3 |
732 (80.1%) 182 (19.9%) |
| PLR | |
| <150 | 567 (62%) |
| ≥150 | 347 (38%) |
| Neoadjuvant treatment | |
| No | 853 (93.3%) |
| Yes | 61 (6.7%) |
| Ajuvant treatment | |
| No Yes |
311 (34.0%) 603 (66.0%) |
AJCC, American Joint Commission on Cancer; CA, carbohydrate antigen; mGPS, modified Glasgow Prognostic Score; LN, lymph node; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; PPPD, pylorus preserving pancreaticoduodenectomy; PrPD, pylorus resecting pancreaticoduodenectomy; TNM, Tumor Node Metastasis.